Bank of America’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bank of America’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-63,716	Closed	-$2.19M	–	8097
2014 Q4	$2.19M	Sell	63,716 -174,814	-73%	-$5.7M	﹤0.01%	3292
2014 Q3	$7.12M	Buy	238,530 +179,595	+305%	+$3.81M	﹤0.01%	2236
2014 Q2	$1.18M	Sell	58,935 -269,121	-82%	-$6.17M	﹤0.01%	3854
2014 Q1	$8.92M	Buy	328,056 +57,630	+21%	+$1.53M	﹤0.01%	1868
2013 Q4	$5.61M	Sell	270,426 -103,542	-28%	-$1.95M	﹤0.01%	2373
2013 Q3	$6.81M	Buy	373,968 +299,305	+401%	+$5.41M	﹤0.01%	2136
2013 Q2	$1.24M	Buy	+74,663	New	+$1.19M	﹤0.01%	3769

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America's AUXL Position: Q1 2015 in Review

Bank of America sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 63,716 shares — an estimated $2.19M sold.

Bank of America first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $8.92M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Bank of America reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Bank of America sold 63,716 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $2.19M.
Bank of America first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Bank of America's AUXILIUM PHARAMCEUTICALS INC position peaked at $8.92M in Q1 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.